Research study Program year 2021 Source: CMS Open Payments

Study

Research payments

$2,833,467

285 payments

Through program year 2021, $2,833,467 in research payments was reported against Study, across 285 payments.

Paid by (largest first): Taro Pharmaceuticals USA, Inc.; Dexcom, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$2,827,374	283
2019	Research	$6,093	2

Breakdown

Who paid Research payments · program years 2019–2021

Taro Pharmaceuticals USA, Inc. $2,827,374 283 payments
Dexcom, Inc. $6,093 2 payments

Who received the money Research payments · program years 2019–2021

Newco 3A Research LLC Organisation paid for research $621,300 48 payments
Fxm Clinical Research Miami Llc Organisation paid for research $491,562 33 payments
Dfw Clinical Research Organisation paid for research $472,425 32 payments
Fxm Clinical Research Miramar LLC Organisation paid for research $438,391 31 payments
FXM Clinical Research Ft. Lauderdale LLC Organisation paid for research $200,008 22 payments
Direct Helpers Research Center Organisation paid for research $184,015 30 payments
Moore Clinical Research Inc. Organisation paid for research $147,137 26 payments
Peak Research Organisation paid for research $46,565 11 payments
South Florida Research Center Organisation paid for research $45,180 5 payments
Evolution Clinical Trials Organisation paid for research $38,201 10 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.